
Structural Biology of Signal Transduction
Graduate students accepted.
Nagar Lab Website
Francesco Bellini Life Sciences Building
3649 promenade Sir-William-Osler
Office: Room 464; Lab: Room 456
Montreal, Quebec H3G 0B1
Tel: 514-398-7272 Lab: 514-398-7271
Fax: 514-398-2983
Email
2001 - PhD, University of Toronto
Our research interests focus on proteins that are involved in signal transduction pathways of the innate immune system. The human immune system is generally divided into two broad categories, the adaptive immune system and the innate immune system. Adaptive immunity relies on a very large repertoire of clonally distributed antigen receptors displayed on lymphocytes and secreted antibodies that have the ability to recognize almost any foreign molecule. Conversely, innate immunity depends on a limited set of germ-line encoded receptors, which recognize distinct molecular patterns on pathogen surfaces. These receptors are strategically expressed on cells that are likely to encounter antigen early in an infection, including cells of the respiratory tract, epithelial cells of the gut and skin, and professional antigen presenting cells. As a result, the innate immune response generally precedes the adaptive immune response.
Specifically, our lab studies components of the Toll-like receptor (TLR) signal tranduction pathway, including the TLR receptors themselves and members of the Interleukin-1 receptor associated kinase (IRAK) family using X-ray crystallography and other biophysical techniques. Using structural analysis, we would like to dissect the molecular basis for specificity of TLR-ligand interactions and the mechanisms by which the IRAKs are regulated. It is hoped that by visualizing the atomic-level details of these proteins and the interactions they make, we can contribute to potential therapies against infectious diseases and autoimmune disorders.
Nagar, B., Hantschel, O., Young, M.A., Scheffzek, K., Veach, D., Bornmann, W., Clarkson, B., Superti-Furga, G. and Kuriyan, J. (2003) “Structural Basis for the Autoinhibition of c-Abl Tyrosine Kinase”. Cell, 112 (6), 859-71.
Hantschel, O., Nagar, B., Guettler, S., Kretzschmar, J., Dorey, K., Kuriyan, J. and Superti-Furga, G. (2003). “A Myristoyl/ Phosphotyrosine Switch Regulates c-Abl”. Cell, 112 (6), 845-57.
Nagar, B., Bornmann, W.G., Pellicena, P., Schindler, T., Veach, D.R., Miller, W.T., Clarkson, B. and Kuriyan, J. (2002). “Crystal structures of the kinase domain of c-Abl in complex with the small molecule inhibitors PD173955 and imatinib (STI-571)”. Cancer Research, 62 (15), 4236-43.
Nagar, B., Jones, R.G., Diefenbach, R.J., Isenman, D.E. and Rini, J.M. (1998). “X-Ray Crystal Structure of C3d: a C3 Fragment and Ligand for Complement Receptor 2”. Science, 280, 1277-1281.
Nagar, B., Overduin, M., Ikura, M. and Rini, J.M. (1996). “Structural Basis of Calcium Induced E-Cadherin Rigidification and Dimerization". Nature, 380, 360-364.